# OCS-05 in Patients With Optic Neuritis

> **NCT04762017** · PHASE2 · COMPLETED · sponsor: **Oculis** · enrollment: 36 (actual)

## Conditions studied

- Optic Neuritis

## Interventions

- **DRUG:** OCS-05 +SoC (corticosteroid) IV administration
- **OTHER:** Placebo + SoC (corticosteroid) IV administration

## Key facts

- **NCT ID:** NCT04762017
- **Lead sponsor:** Oculis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-10
- **Primary completion:** 2024-09-16
- **Final completion:** 2024-09-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762017, "OCS-05 in Patients With Optic Neuritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04762017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*